Metagenomi Therapeutics Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,117 | 61,181 | 102,558 | 140,603 | 0 |
| Marketable Securities | 249,470 | 238,740 | 224,847 | 130,579 | 0 |
| Receivables | 589 | 1,648 | 2,082 | 2,451 | 0 |
| TOTAL | $282,293 | $307,579 | $335,643 | $278,273 | $0 |
| Non-Current Assets | |||||
| PPE Net | 19,719 | 20,711 | 20,960 | 21,542 | N/A |
| Investments And Advances | 10,577 | 10,676 | 10,676 | 10,676 | 0 |
| Other Non-Current Assets | 45,759 | 46,939 | 48,124 | 54,351 | 0 |
| TOTAL | $76,055 | $78,326 | $79,760 | $86,569 | $N/A |
| Total Assets | $358,348 | $385,905 | $415,403 | $364,842 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,103 | 3,453 | 6,843 | 1,791 | 0 |
| Accrued Expenses | 8,840 | 10,984 | 7,079 | 11,472 | 0 |
| Other current liabilities | N/A | N/A | 837 | 837 | 0 |
| TOTAL | $45,692 | $52,810 | $70,701 | $68,861 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 29,053 | 32,977 | 48,294 | 48,068 | N/A |
| Other Non-Current Liabilities | 44,452 | 46,348 | 48,759 | 49,881 | 0 |
| TOTAL | $56,883 | $63,676 | $69,069 | $80,807 | $N/A |
| Total Liabilities | $102,575 | $116,486 | $139,770 | $149,668 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,424 | 37,429 | 37,464 | N/A | N/A |
| Common Shares | 4 | 4 | 4 | N/A | 0 |
| Retained earnings | -199,604 | -180,831 | -170,092 | -144,944 | 0 |
| Other shareholders' equity | 1,639 | -265 | -278 | 350,661 | 0 |
| TOTAL | $255,773 | $269,419 | $275,633 | $215,174 | $0 |
| Total Liabilities And Equity | $358,348 | $385,905 | $415,403 | $364,842 | $0 |